Arcus Biosciences Inc (RCUS)
US Market

Arcus Biosciences (RCUS) Financial Statements


Arcus Biosciences Financial Overview

Arcus Biosciences's market cap is currently ―. The company's EPS TTM is $-3.948; its P/E ratio is -4.55; Arcus Biosciences is scheduled to report earnings on November 6, 2023, and the estimated EPS forecast is $-1.15. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 29.00M$ 25.00M$ 33.66M$ 33.58M$ 26.76M
Gross Profit$ 29.00M$ 25.00M$ 33.66M--
EBIT$ -74.00M$ -86.00M$ -74.44M$ -64.38M$ -66.12M
EBITDA$ -74.00M$ -86.00M$ -73.02M$ -62.82M$ -64.62M
Net Income Common Stockholders$ -75.00M$ -80.00M$ -67.46M$ -64.92M$ -66.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 930.00M$ 954.00M$ 1.01B$ 1.05B$ 1.17B
Total Assets$ 1.22B$ 1.25B$ 1.34B$ 1.39B$ 1.48B
Total Debt$ 0.00$ 0.00$ 0.00$ 119.19M$ 121.34M
Net Debt$ -930.00M$ -954.00M$ -1.01B$ -929.59M$ -1.05B
Total Liabilities$ 654.00M$ 654.00M$ 688.00M$ 695.12M$ 729.39M
Stockholders Equity$ 566.00M$ 600.00M$ 657.00M$ 698.70M$ 747.39M
Cash Flow-
Free Cash Flow$ -62.00M$ -101.00M$ -70.12M$ -82.28M$ -72.32M
Operating Cash Flow$ -57.00M$ -98.00M$ -69.74M$ -80.96M$ -65.30M
Investing Cash Flow$ 26.00M$ 129.00M$ 46.81M$ 23.45M$ -215.20M
Financing Cash Flow$ 23.00M$ 1.00M$ 11.20M$ 2.53M$ 4.35M
Currency in USD

Arcus Biosciences Earnings and Revenue History

Arcus Biosciences Debt to Assets

Arcus Biosciences Cash Flow

Arcus Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis